Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy

Cengiz Aras¹; Fevzi Senturk¹; Sevil Karaman Erdur¹; Mehmet Selim Kocabora¹; Mahmut Dogramaci²; Cahit Burke¹; Efe Aras³

DOI: 10.5935/0004-2749.2023-0001

1. Department of Ophthalmology, Medicine Faculty, Istanbul Medipol University, Istanbul, Turkey
2. Department of Ophthalmology, The Princess Alexandra Hospital NHS Trust, London, UK
3. Medicine Faculty, Yeditepe University, Istanbul, Turkey

Corresponding author

Cengiz Aras
E-mail: [email protected]

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.

Read in Portuguese Print PDF English

How to cite this article:

Aras C, Senturk F, Erdur SK, Kocabora MS, Dogramaci M, Burke C, et al. Preoperative co-application of bevacizumab and tissue plasminogen activator in vitrectomy for proliferative diabetic retinopathy. Arq. Bras. Oftalmol. 2024;87(2):. 10.5935/0004-2749.2023-0001

Export citation